TouchINFECTIOUSDISEASES had the pleasure of talking to Prof. Dolores Carrer (INIMEC-CONICET-UNC, Córdoba, Argentina) about the current treatments available for cutaneous leishmaniasis and the promising, new generation of treatments on the horizon. Her talk entitled ‘Topical treatments for cutaneous leishmaniasis’ was presented at the ISNTD d3 Virtual Conference, 24-25 February 2021.
Questions
- What are the advantages of topical agents in the treatment of cutaneous leishmaniasis? (0:37)
- What are the most promising topical agents in preclinical development? (2:58)
- Could you tell us a little about the challenges and opportunities of liposomal miltefosine? (4:10)
Disclosures: Prof. Dolores Carrer has nothing to disclose in relation to this video interview.
Support: Interview and filming supported by Touch Medical Media.
Filmed in coverage of ISNTD d3 2021 Virtual Conference.
